SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001683168-23-004045
Filing Date
2023-06-09
Accepted
2023-06-09 16:30:15
Documents
7
Period of Report
2023-07-20

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT phio_def14a.htm DEF 14A 454976
2 GRAPHIC image_001.jpg GRAPHIC 2100
3 GRAPHIC image_002.jpg GRAPHIC 2109
4 GRAPHIC image_006.jpg GRAPHIC 24896
5 GRAPHIC image_009.jpg GRAPHIC 24962
6 GRAPHIC image_007.jpg GRAPHIC 1860214
7 GRAPHIC image_008.jpg GRAPHIC 377408
  Complete submission text file 0001683168-23-004045.txt   3610435
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36304 | Film No.: 231005761
SIC: 2834 Pharmaceutical Preparations